ITEOS THERAPEUTICS INC's ticker is ITOS and the CUSIP is 46565G104. A total of 82 filers reported holding ITEOS THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $4,877,000 | +215.3% | 104,755 | +82.9% | 2.59% | +178.4% |
Q3 2021 | $1,547,000 | -1.5% | 57,286 | -6.5% | 0.93% | -13.9% |
Q2 2021 | $1,571,000 | -55.1% | 61,248 | -40.1% | 1.08% | -40.3% |
Q1 2021 | $3,496,000 | -25.3% | 102,286 | -26.1% | 1.81% | -15.3% |
Q4 2020 | $4,680,000 | +228.4% | 138,384 | +139.6% | 2.13% | +133.0% |
Q3 2020 | $1,425,000 | – | 57,751 | – | 0.92% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MPM ASSET MANAGEMENT LLC | 2,738,785 | $29,989,696 | 16.06% |
MPM BioImpact LLC | 1,745,943 | $19,118,076 | 5.10% |
Saturn V Capital Management LP | 994,756 | $10,892,578 | 4.56% |
Boxer Capital, LLC | 1,804,058 | $19,754,435 | 1.05% |
RA Capital Management | 4,417,259 | $48,368,986 | 0.95% |
683 Capital Management, LLC | 810,000 | $8,869,500 | 0.69% |
Ikarian Capital, LLC | 346,471 | $3,793,857 | 0.46% |
Ikarian Capital, LLC | 3,056 | $3,346,320 | 0.40% |
BVF INC/IL | 1,259,476 | $13,791,262 | 0.37% |
DAFNA Capital Management LLC | 98,560 | $1,079,232 | 0.34% |